September 21, 2023
Webinars
ATA Telehealth Technology Special Interest Group

What You Need to Know: A Review of Notable Telehealth Tools, Software, and Technology Infrastructure

Industry leaders dive deep into what’s new in the world of telehealth technology, plus examine novel applications of digitally-enabled tech. Our panel also discuss key considerations in technology selection, including diversity, equity and inclusion issues, usability, regulatory and legal topics, and overall best practices in choosing digital devices.

Hosted by the ATA Telehealth Technology Special Interest Group

 

Slides-Telehealth Technology Roundup »









Related Resources


Webinars


Telehealth for Diabetes Care: A Program and Policy Framework
April 25, 2024
ATA
Discover the transformative power of telehealth for diabetes management, from education and prevention to comprehensive care, as evidenced by the success stories from various programs. This enlightening webinar delves into the significant impact of telehealth on both preventing and managing diabetes, along with the evolving landscape of policies shaping its future.

   View Video
Webinars
Maximizing Provider Capacity and Improving Access with Asynchronous Care
April 5, 2024
ATA's Async Telehealth Special Interest Group
With increasing provider shortages, patient wait times, and physician burnout, maximizing clinical capacity has become more critical than ever. Discover why leading direct-to-consumer health brands and provider organizations are turning to the power of asynchronous care to address these challenges.

   View Video
Webinars


Policy Update: Navigating the DEA's Geographic Red Flag in Remote Prescribing
March 29, 2024
ATA
This policy update dives into the geographic red flag issue specific to the Drug Enforcement Administration’s (DEA) oversight of remote prescribing of controlled substances. We clarify the issue, outline the key players involved, discuss potential DEA rulemaking as well as its potential impact on state policies, and highlight the urgent stakeholder statement urging the DEA to address this issue.

   View Video